abstract |
The invention concerns the use of beta-naphthoquinone for making medicines with an inhibiting effect on the release of glutamate by the brain, said compounds corresponding to formula (I) wherein: R represents a -NH-CO-NH2, -NH-CO-CH3, or -OH group, glucuronide derivatives corresponding to formula (II) and their pharmaceutically acceptable additive salts with acids. The invention is applicable to neurological diseases. |